Impaired ventilation is not independently associated with 28-day mortality in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) Source: Virtual Congress 2021 – COVID-19 acute respiratory distress syndrome Year: 2021
Aiding paramedics recognition of type two respiratory failure (T2RF) Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015
Community-acquired pneumonia (CAP) and mortality risk in patients with congestive heart failure (CHF) Source: Eur Respir J 2002; 20: Suppl. 38, 443s Year: 2002
Pathophysiology of obesity and respiratory failure Source: Annual Congress 2004 - Noninvasive ventilation for respiratory failure in obese patients Year: 2004
Risk factors contributing to mortality in patients with COPD developing acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007
LATE-BREAKING ABSTRACT: Risk factors for hospitalization and death in elderly smokers with chronic obstructive pulmonary disease (COPD) and/or chronic heart failure (CHF) Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016
Acute respiratory failure (ARF) and severe sepsis (SS) in community acquired pneumonia (CAP): different outcomes? Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Increasing severity with unchanged in-hospital mortality in acute hypercapnic respiratory failure (AHRF) at a respiratory ward-based non-invasive ventilation (NIV) unit Source: Annual Congress 2013 –New evidence for NIV in the acute setting Year: 2013
Non-invasive ventilation (NIV) in community-acquired pneumonia CAP) and severe acute respiratory failure (ARF): Effectiveness and risk factors for failure and mortality Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure Year: 2011
Management of acute respiratory failure in restrictive disorders (obesity excluded) Source: Eur Respir Mon; 2008: 41: 37–46 Year: 2008
Cardiovascular failure versus infectious disease as causes of exacerbation of COPD in a respiratory ICU Source: Eur Respir J 2006; 28: Suppl. 50, 179s Year: 2006
Algorithm of respiratory support (RS) in the acute respiratory failure (ARF) Source: Eur Respir J 2003; 22: Suppl. 45, 444s Year: 2003
Age cohort mortality differences for respiratory and cardiovascular causes of death Source: Eur Respir J 2001; 18: Suppl. 33, 151s Year: 2001
Factors affecting one year mortality of hospitalized patients with COPD exacerbation and respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 321s Year: 2007
A dedicated COPD team reduces mortality in patients with type 2 respiratory failure Source: Eur Respir J 2004; 24: Suppl. 48, 312s Year: 2004
The changing pattern of acute respiratory distress syndrome over time: a comparison of two periods}, Source: Eur Respir J 2012; 40: 589-595 Year: 2012
In hospitalized COPD exacerbation (COPDE) patients a 30-day readmission is associated with a progressive increased risk of mortality Source: International Congress 2015 – COPD: interesting notes Year: 2015
Relationship between severity of chronic heart failure (CHF) and sleep related breathing disorders (SRBD) Source: Eur Respir J 2006; 28: Suppl. 50, 815s Year: 2006
Comorbidity: a distinctive feature of elderly respiratory patients Source: Eur Respir Mon; 2009: 43: 205–216 Year: 2009
Left heart dysfunction in acute exacerbation of COPD: Only risk factor or even outcome? Source: International Congress 2014 – The assessment of comorbidities Year: 2014